According to GlobalData’s medical device pipeline database, 34 Reconstruction Meshes devices are in various stages of development globally. GlobalData’s report Reconstruction Meshes provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Smarter leaders trust GlobalData
Of these devices, 19 are in active development, while the remaining 15 are in an inactive stage of development. There are 12 products in the early stages of development, and the remaining seven are in the late stages of development.
Reconstruction Meshes are surgically implantable woven sheets that are used to repair or support organs and other tissues. The meshes are made either from synthetic material and/or bioengineered from animal tissues. Reconstruction Meshes are generally available in multiple sizes, thicknesses, and pore sizes, however for this market model the meshes are segmented based on the materials used to make them. Reconstruction Meshes include Synthetic Mesh, Biologic Mesh, and Hybrid Mesh. One unit refers to one sheet of Synthetic/Biologic/Hybrid Reconstruction Mesh. Reconstruction Meshes specifically indicated for hernia repair were excluded from this market model, the data for which are presented in GlobalData’s Hernia Repair Devices market model.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Reconstruction Meshes pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Reconstruction Meshes devices. Overall, most of these Reconstruction Meshes pipeline devices are being developed by private entities.
Key players involved in the active development of Reconstruction Meshes include T&R Biofab, Beijing Biosis Healing Biological Technology, Biorez, Boston Scientific, DECO Med, DSM Biomedical, Fibralign, Kensey Nash, Lazzaro Medical and LifeCell.
For a complete picture of the developmental pipeline for Reconstruction Meshes devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
